ESMO-magnitude of clinical benefit scale version 1.1. Ann Oncol. 2017;28(10):2340–66. https://doi.org/10.1093/annonc/mdx310. Article PubMed CAS Google Scholar van Harten W, Ijzerman MJ. Responsible pricing in value-based assessment of cancer drugs: real-world data are an inevitable ...
Thermo-acoustic TRL2, if it could be made to meet the requirements, would be the most affordable and the cheapest option, but considerably more investment in research and manufacturing tooling is required to realise this benefit. Clean cookstoves (minus electricity) although the cheapest option ...